| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 128.32 | 28 |
| Intrinsic value (DCF) | 4106.56 | 4006 |
| Graham-Dodd Method | 41.57 | -58 |
| Graham Formula | 244.70 | 145 |
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.